These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Heart rate variability in children with beta-thalassemia major]. Ma QL; Wang B; Fu GH; Chen GF; Chen ZY Zhongguo Dang Dai Er Ke Za Zhi; 2011 Aug; 13(8):654-6. PubMed ID: 21849117 [TBL] [Abstract][Full Text] [Related]
3. Heart Rate Variability for Early Detection of Iron Overload Cardiomyopathy in β-Thalassemia Patients. Koonrungsesomboon N; Tantiworawit A; Phrommintikul A; Saekho S; Srichairattanakool S; Chattipakorn N Hemoglobin; 2015; 39(4):281-6. PubMed ID: 26029793 [TBL] [Abstract][Full Text] [Related]
4. Heart Rate Variability for Early Detection of Cardiac Iron Deposition in Patients with Transfusion-Dependent Thalassemia. Silvilairat S; Charoenkwan P; Saekho S; Tantiworawit A; Phrommintikul A; Srichairatanakool S; Chattipakorn N PLoS One; 2016; 11(10):e0164300. PubMed ID: 27737009 [TBL] [Abstract][Full Text] [Related]
6. Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction. Björkander I; Forslund L; Ericson M; Rehnqvist N; Hjemdahl P; Kahan T Clin Physiol Funct Imaging; 2009 May; 29(3):201-8. PubMed ID: 19254330 [TBL] [Abstract][Full Text] [Related]
7. Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients. Wijarnpreecha K; Siri-Angkul N; Shinlapawittayatorn K; Charoenkwan P; Silvilairat S; Siwasomboon C; Visarutratna P; Srichairatanakool S; Tantiworawit A; Phrommintikul A; Chattipakorn SC; Chattipakorn N PLoS One; 2015; 10(6):e0130837. PubMed ID: 26083259 [TBL] [Abstract][Full Text] [Related]
8. Echocardiographic study in ex-thalassemic patients with iron overload, preliminary observations during phlebotomy therapy. Mariotti E; Agostini A; Angelucci E; Lucarelli G; Sgarbi E Bone Marrow Transplant; 1993; 12 Suppl 1():106-7. PubMed ID: 8374547 [TBL] [Abstract][Full Text] [Related]
9. Early impairment of myocardial function in young patients with beta-thalassemia major. Magrì D; Sciomer S; Fedele F; Gualdi G; Casciani E; Pugliese P; Losardo A; Ferrazza G; Pasquazzi E; Schifano E; Mussino E; Quaglione R; Piccirillo G Eur J Haematol; 2008 Jun; 80(6):515-22. PubMed ID: 18284626 [TBL] [Abstract][Full Text] [Related]
10. Heart rate variability in myocardial infarction and heart failure. Chattipakorn N; Incharoen T; Kanlop N; Chattipakorn S Int J Cardiol; 2007 Sep; 120(3):289-96. PubMed ID: 17349699 [TBL] [Abstract][Full Text] [Related]
11. Heart rate variability in infants with heart failure due to congenital heart disease: reversal of depressed heart rate variability by propranolol. Buchhorn R; Hulpke-Wette M; Nothroff J; Paul T Med Sci Monit; 2002 Oct; 8(10):CR661-6. PubMed ID: 12388917 [TBL] [Abstract][Full Text] [Related]
12. Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up. Casale M; Cinque P; Ricchi P; Costantini S; Spasiano A; Prossomariti L; Minelli S; Frega V; Filosa A Eur J Haematol; 2013 Jul; 91(1):69-73. PubMed ID: 23581970 [TBL] [Abstract][Full Text] [Related]
13. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major. Grosse R; Lund U; Caruso V; Fischer R; Janka GE; Magnano C; Engelhardt R; Dürken M; Nielsen P Ann N Y Acad Sci; 2005; 1054():429-32. PubMed ID: 16339692 [TBL] [Abstract][Full Text] [Related]
14. Heart rate variability is decreased in chronic kidney disease but may improve with hemoglobin normalization. Furuland H; Linde T; Englund A; Wikström B J Nephrol; 2008; 21(1):45-52. PubMed ID: 18264936 [TBL] [Abstract][Full Text] [Related]
15. High nontransferrin bound iron levels and heart disease in thalassemia major. Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228 [TBL] [Abstract][Full Text] [Related]
16. Spinal cord compression and extramedullary hematopoiesis in young Egyptian beta-thalassemia patients. Tantawy AA; Adly AA; Mahdy SA; Kamel GZ Hemoglobin; 2009; 33(6):448-62. PubMed ID: 19958190 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ladis V; Chouliaras G; Berdousi H; Kanavakis E; Kattamis C Ann N Y Acad Sci; 2005; 1054():445-50. PubMed ID: 16339695 [TBL] [Abstract][Full Text] [Related]
18. Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. Lanza GA; Pitocco D; Navarese EP; Sestito A; Sgueglia GA; Manto A; Infusino F; Musella T; Ghirlanda G; Crea F Eur Heart J; 2007 Apr; 28(7):814-20. PubMed ID: 17371783 [TBL] [Abstract][Full Text] [Related]
19. Heart failure in beta-thalassemia syndromes: a decade of progress. Hahalis G; Alexopoulos D; Kremastinos DT; Zoumbos NC Am J Med; 2005 Sep; 118(9):957-67. PubMed ID: 16164878 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of QT dispersion in beta thalassaemia major patients. Ulger Z; Aydinok Y; Levent E; Gurses D; Ozyurek AR Am J Hematol; 2006 Dec; 81(12):901-6. PubMed ID: 16924653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]